相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Excess Mortality in Patients with Advanced Chronic Hepatitis C Treated with Long-Term Peginterferon
Adrian M. Di Bisceglie et al.
HEPATOLOGY (2011)
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
W. Alazawi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C
Marc G. Ghany et al.
GASTROENTEROLOGY (2010)
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Gary L. Davis et al.
GASTROENTEROLOGY (2010)
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study
E. K. Manesis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The history of the natural history of hepatitis C (1968-2009)
Leonard B. Seeff
LIVER INTERNATIONAL (2009)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The natural history of hepatitis C with severe hepatic fibrosis
Adam Lawson et al.
JOURNAL OF HEPATOLOGY (2007)
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients
Angelo Sangiovanni et al.
HEPATOLOGY (2006)
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
AM Di Bisceglie et al.
JOURNAL OF HEPATOLOGY (2005)
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
ML Shiffman et al.
GASTROENTEROLOGY (2004)
Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications
L Benvegnù et al.
GUT (2004)
Evolution of the HALT-C trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
WM Lee et al.
CONTROLLED CLINICAL TRIALS (2004)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
分享论文
